United States · Bill · HR
H.R. 1304 (103rd)
To amend the Internal Revenue Code of 1986 to impose an excise tax on sales of syringes and intravenous systems which do not meet antineedlestick prevention standards.
Introduced
10 March 1993
Last action
—
Status
Sponsor introductory remarks on measure. (CR E2348)
Sponsors
—
Subjects
Discovery layer
Source updated
2 January 2025
Summary
Amends the Internal Revenue Code to impose an excise tax through 1999 on taxable first sales of syringes and intravenous systems to health care providers which do not meet antineedlestick prevention standards. Directs the Commissioner of the Food and Drug Administration to prescribe safety standards for syringes, and appropriate components of intravenous systems, to prevent accidental needlestick injuries to health care providers.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 10 March 1993
Introduced in House (PDF)
Introduced in House · EN · 10 March 1993
Introduced in House
summary · EN · 10 March 1993
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/house-bill/1304
- Open data entity: https://api.congress.gov/v3/bill/103/hr/1304